7Baggers
 Published on: 2025-11-16 16:56:09  newser.com Sun, 16 Nov 2025 22:56:09 GMT
 Bio Green Med Solution’s Strategic Shift and Q3 Results  TipRanks Fri, 14 Nov 2025 05:09:58 GMT
 published on: 2025-11-16 16:56:09  newser.com Thu, 06 Nov 2025 03:04:21 GMT
 exit strategy if you’re trapped in cyclacel pharmaceuticals inc.  newser.com Mon, 03 Nov 2025 07:22:41 GMT
 published on: 2025-11-03 01:08:43  newser.com Mon, 03 Nov 2025 07:08:43 GMT
 published on: 2025-11-01 02:12:11  newser.com Sat, 01 Nov 2025 07:12:11 GMT
 published on: 2025-10-31 03:39:06  newser.com Fri, 31 Oct 2025 08:39:06 GMT
 published on: 2025-10-31 01:03:58  newser.com Fri, 31 Oct 2025 06:03:58 GMT

Cyclacel Pharmaceuticals, Inc
(NASDAQ:CYCC) 

CYCC stock logo

Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's oncology development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase I clinical trial f...

Founded: 1996
Full Time Employees: 12
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends